Scientific Letters
Vol. 15 No. 1 (2023): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment
erythrocyte lifespan in patients with thalassemia
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: July 14, 2023
Accepted: August 2, 2023
Accepted: August 2, 2023
791
Views
501
Downloads
125
HTML
Authors
Background: Thalassemia comprises a diverse group of genetic disorders that affects the synthesis of globin chains, with a global distribution. The use of erythrocyte lifespan (ELS) to assess differences among patients with different types of thalassemia and the efficacy of splenectomy has not been implemented.
Downloads
Download data is not yet available.
Citations
How to Cite
“Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment: erythrocyte lifespan in patients with thalassemia ” (2023) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023050. doi:10.4084/MJHID.2023.050.
Copyright (c) 2023 xiaolin yin, Jingting Luo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
